The SGC catalyzes research in new areas of human biology and drug discovery by focusing explicitly on less well-studied areas of the human genome. The SGC accelerates research in these new areas by making all its research output available to the scientific community with no strings attached, and by creating an open collaborative network of scientists in hundreds of universities around the world and in eight global pharmaceutical companies.

Research

Structural Genomics Consortium

Aled Edwards

Max Morgan

Cheryl Arrowsmith

Michael Sundström

Timothy Willson

Stefan Knapp

Susan McCormick

Management

Finance and Administration

Research and Development

Leadership Team

Clinical Operations

Teams at Structural Genomics Consortium

Management

Finance and Administration

Research and Development

Leadership Team

Clinical Operations